STAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/ba4b4d858f460d563cd5e438050dca21b4af414a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more"></iframe>